---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-003740"
form_type: "8-K"
ticker: "LUCD"
cik: "0001799011"
company_name: "Lucid Diagnostics Inc."
filed_at: "2025-04-11T23:59:59+00:00"
generated_at: "2026-05-23T16:17:04.097183+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Lucid Diagnostics closes $16.1M public offering of 14.4M shares at $1.20/share

## Summary
- Closed sale of 14,375,000 shares of common stock at $1.20/share; underwriters' option exercised in full.
- Net proceeds expected to be approximately $16.1 million after underwriting discounts and expenses.
- Proceeds to be used for working capital and general corporate purposes.
- Canaccord Genuity acted as sole bookrunner; Maxim Group as co-manager of the offering.
- Offering made under existing shelf registration statement S-3 effective Dec 6, 2022.

## SEC filing metadata
- accession: 0001641172-25-003740
- form_type: 8-K
- ticker: LUCD
- cik: 0001799011
- company_name: Lucid Diagnostics Inc.
- filed_at: 2025-04-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799011/000164117225003740/0001641172-25-003740-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799011/000164117225003740/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-003740
- JSON: https://secwatch.observer/filing/0001641172-25-003740.json
- Plain text: https://secwatch.observer/filing/0001641172-25-003740.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.